IMMUNEX CORP /DE/
10-Q, EX-27, 2000-11-07
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: IMMUNEX CORP /DE/, 10-Q, 2000-11-07
Next: COLORADO MEDTECH INC, SC 13D/A, 2000-11-07



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated balance sheet as of September 30, 2000 and the consolidated
statement of operations for the nine-month period ended September 30, 2000 and
is qualified in its entirety to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          97,962
<SECURITIES>                                   719,723
<RECEIVABLES>                                   90,953
<ALLOWANCES>                                       940
<INVENTORY>                                     21,207
<CURRENT-ASSETS>                               936,503
<PP&E>                                         277,584
<DEPRECIATION>                                  91,860
<TOTAL-ASSETS>                               1,216,378
<CURRENT-LIABILITIES>                          219,127
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       852,568
<OTHER-SE>                                   (306,155)
<TOTAL-LIABILITY-AND-EQUITY>                 1,216,318
<SALES>                                        580,052
<TOTAL-REVENUES>                               611,161
<CGS>                                          170,172
<TOTAL-COSTS>                                  533,296
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                   382
<INTEREST-EXPENSE>                               9,864
<INCOME-PRETAX>                                106,361
<INCOME-TAX>                                     1,165
<INCOME-CONTINUING>                            105,196
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   105,196
<EPS-BASIC>                                       0.21
<EPS-DILUTED>                                     0.19


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission